Our findings thus indicate that 5-FU chemotherapy exerts its efficacy, at least in part, through activating Fas expression in MDSCs, to suppress MDSCs, to increase T cell level in colon tumor-bearing mice and human colorectal cancer. The gene discussed is FAS; the disease is colorectal cancer.